Market Samachar
STAT
·
GLOBAL
·
Detailed data show Pfizer’s monthly obesity drug continues to show potential - statnews.com
As reported by STAT
Detailed data from a midstage study offered further evidence that the obesity drug Pfizer acquired from the biotech Metsera could be dosed monthly.
▸ MARKET SAMACHAR VIEW
NEUTRAL
Read full article on STAT ↗
Market Samachar is a news aggregator. This article was originally published by
STAT. Tap the button above to read the full story on their site.
🔥 Hot Now
Top stories across markets in the last hour
More from Market Samachar